Oklahoma City, OK
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Oklahoma Blood Institute, founded in 1977, is a major nonprofit in the Health Care sector that reported $155.9M in total revenue in fiscal year 2024. Expenses of $149.7M left a modest 4% surplus.
OKLAHOMA BLOOD INSTITUTE'S (OBI) MISSION IS TO BE THE DONOR-TO-PATIENT LIFELINE BY PROVIDING OUR COMMUNITIES AND MEDICAL PARTNERS SECURITY BY MEETING BLOOD TRANSFUSION AND HEALTH CARE NEEDS.
SERVICE FEES FOR BLOOD PRODUCTS: AS THE SIXTH-LARGEST BLOOD CENTER IN THE U.S, OBI COLLECTS, TESTS, PROCESSES, AND DISTRIBUTES MORE THAN 450,000 LIFE-SAVING BLOOD PRODUCTS ANNUALLY IN 16 BLOOD...
SERVICE FEES FOR BLOOD PRODUCTS: AS THE SIXTH-LARGEST BLOOD CENTER IN THE U.S, OBI COLLECTS, TESTS, PROCESSES, AND DISTRIBUTES MORE THAN 450,000 LIFE-SAVING BLOOD PRODUCTS ANNUALLY IN 16 BLOOD DONATION CENTERS ACROSS OKLAHOMA, ARKANSAS, AND TEXAS. OUR COMPLEX TECHNOLOGICAL INFRASTRUCTURE AND RARE MEDICAL EXPERTISE ALLOW OBI TO PROVIDE SAFE AND ADEQUATE BLOOD TO PATIENTS AT MORE THAN 230 AREA HOSPITALS, MEDICAL FACILITIES, AND AIR AMBULANCES ACROSS ALL THREE STATES. OUR RIGOROUS SAFETY MEASURES AND THE TIRELESS EFFORTS OF OUR MEDICAL LABORATORY STAFF ENSURE THAT THE DONATED BLOOD IS SAFE AND AVAILABLE TO SAVE LIVES.
TESTING SERVICES: WHILE MANY BLOOD CENTERS OUTSOURCE THEIR TESTING, OBI MAINTAINS AN INHOUSE TESTING LABORATORY TO PROVIDE A RAPID RESPONSE TO PROCESSING UNITS. WITH EVERY DONATION, OUR DILIGENT...
TESTING SERVICES: WHILE MANY BLOOD CENTERS OUTSOURCE THEIR TESTING, OBI MAINTAINS AN INHOUSE TESTING LABORATORY TO PROVIDE A RAPID RESPONSE TO PROCESSING UNITS. WITH EVERY DONATION, OUR DILIGENT LABORATORY STAFF PERFORMS MULTIPLE TESTS TO ENSURE BLOOD PRODUCTS ARE SAFE AND READY TO BE TRANSFUSED TO LOCAL PATIENTS. AS A FULLY LICENSED AND CERTIFIED LABORATORY, OBI MAINTAINS THE HIGHEST STANDARDS AND LEADS THE NATION IN APPLYING CUTTING-EDGE TECHNOLOGY TO CREATE THE SAFEST BLOOD PRODUCTS POSSIBLE. OBI'S TESTING LABORATORY PROVIDES A WIDE SCOPE OF SAFETY TESTING FOR SEVERAL BLOOD-BORN CONDITIONS, LIKE HIV, HEPATITIS C, AND WEST NILE VIRUS, TO ENSURE BLOOD PRODUCTS ARE OF THE HIGHEST QUALITY. IF ANY SAMPLE IS POSITIVE FOR THESE ISSUES, OUR STAFF WILL NOTIFY THE DONOR AND REFER THEM FOR ADDITIONAL TESTING AND TREATMENT. AFTER THE BLOOD SAMPLE HAS BEEN CLEARED, ADDITIONAL HEALTH SCREENING TESTING IS PERFORMED. FOR EXAMPLE, WE TEST THE CHOLESTEROL LEVEL OF EVERY DONOR AS PART OF OUR STANDARD DONATION PROCESS. IN ADDITION TO OUR ROUTINE TESTING OF UNITS FOR OUR HOSPITAL PARTNERS, WE ALSO WORK TOGETHER TO ASSIST OTHER BLOOD CENTERS, CLINICS, AND ORGAN DONATION ORGANIZATIONS WITH NEEDED TESTING. OUR LABORATORY'S TECHNOLOGY PROVIDES THESE CLIENTS WITH THE IMPECCABLY EFFICIENT TURNAROUND REQUIRED FOR HIGHLY SPECIALIZED BLOOD TESTING. MAINTAINING STRICT AABB-ACCREDITATION AND FDA-LICENSING STANDARDS, OUR LAB PROVIDES NUCLEIC ACID TESTING AND SEROLOGICAL AND VIRAL MARKER SCREENING TESTS, INCLUDING A WIDE RANGE OF SCREENING ASSAYS. CONFIRMATORY/SUPPLEMENTAL ASSAYS AND REFERRAL TESTING SERVICES ARE ALSO OFFERED.
PATIENT CARE REVENUE: THERAPEUTIC APHERESIS SERVICES FOR PATIENTS AT AREA HOSPITALS ARE PROVIDED BY SPECIALLY TRAINED REGISTERED NURSES UNDER THE DIRECTION OF TRANSFUSION MEDICINE PHYSICIANS...
PATIENT CARE REVENUE: THERAPEUTIC APHERESIS SERVICES FOR PATIENTS AT AREA HOSPITALS ARE PROVIDED BY SPECIALLY TRAINED REGISTERED NURSES UNDER THE DIRECTION OF TRANSFUSION MEDICINE PHYSICIANS. PATIENTS UNDERGO TREATMENTS THAT REMOVE HARMFUL PROTEINS, CHEMICALS OR CELLS IN THE BLOOD THAT CONTRIBUTE TO A VARIETY OF LIFE-THREATENING DISEASES OR TRANSPLANT COMPLICATIONS. BASED ON PATIENTS' CONDITIONS, SPECIFIC OFFENDING AGENTS OR COMPONENTS OF THE BLOOD ARE ISOLATED AND IRRADIATED OR REMOVED. AFTER THIS INTRICATE PROCESSING, PATIENTS RECEIVE THEIR TREATED BLOOD TO RESTORE HEALTH.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $155,925,006 | $146,202,331 | +0.1% |
| Expenses | $149,733,070 | $140,507,319 | +0.1% |
| Net Income | $6,191,936 | $5,695,012 | +0.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| David R Carpenter | Board Vice Chairman | 3.0 |
Officer
Director
|
$0 | $0 | $0 |
| John B Armitage MD | President & CEO | 50.0 |
Officer
Director
|
$830,992 | $79,913 | $910,905 |
| Randall G Stark | Treasurer & CFO | 50.0 |
Officer
Director
|
$310,664 | $50,121 | $360,785 |
| Richard Boatsman MD | Board Chairman | 3.0 |
Officer
Director
|
$0 | $0 | $0 |
| Craig Sperry | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| David A Flack | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| Evan Vincent | Director | 1.0 |
Director
|
$12,000 | $0 | $12,000 |
| Frank Barnett | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| Garland Wilkinson | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Gary L Patzkowsky DO | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| Gary Mitchell | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| Henry J Hood | Director | 1.0 |
Director
|
$12,000 | $0 | $12,000 |
| Jay A Gregory | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| Joe M Hodges | Director | 2.0 |
Director
|
$1,500 | $0 | $1,500 |
| Judy G Parker | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| Kristi R Weaber | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Kym Koch-Thompson | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| Larry Bookman MD | Director | 3.0 |
Director
|
$12,000 | $0 | $12,000 |
| Michelle Powers | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| Paul Stout | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| Randal C Juengel MD | Director | 2.0 |
Director
|
$12,000 | $0 | $12,000 |
| Scott Calhoon | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Theodore Violett | Associate Director | 1.0 |
Director
|
$0 | $0 | $0 |
| W H Oehlert | Director | 1.0 |
Director
|
$0 | $0 | $0 |
| Charles Mooney | Vice Pres-Bio Development | 50.0 |
Officer
|
$223,923 | $61,590 | $285,513 |
| Jason L Padgham | Vice Pres-Technical Operations (END: 5/3/24) | 50.0 |
Officer
|
$143,364 | $17,909 | $161,273 |
| John N Marcellus | Chief Information Officer | 50.0 |
Officer
|
$214,142 | $52,343 | $266,485 |
| Kimberly J Van Antwerpen | Chief Operations Officer | 50.0 |
Officer
|
$311,410 | $37,547 | $348,957 |
| Laura S McClannan | Vice Pres-Quality Mgmt | 50.0 |
Officer
|
$219,634 | $28,593 | $248,227 |
| Marlena E Frye | Vice Pres-Donor Services | 50.0 |
Officer
|
$169,408 | $43,277 | $212,685 |
| Tamara J Kirkwood | Vice Pres-CR & DR | 50.0 |
Officer
|
$220,318 | $29,934 | $250,252 |
| Terry Ridenour | Vice Pres-Center Admin & Ops | 50.0 |
Officer
|
$208,199 | $30,801 | $239,000 |
| Walter J Linz | Chief Medical Officer | 50.0 |
Officer
|
$451,766 | $121,486 | $573,252 |
| Joseph R McNeil | Vice Pres-Human Resources | 50.0 |
Key Emp
|
$183,346 | $40,214 | $223,560 |
| Justin R Redwine | Chief Technology Officer | 50.0 |
Key Emp
|
$181,065 | $58,704 | $239,769 |
| Michael E Stevenson | Medical Director | 50.0 |
Key Emp
|
$271,367 | $29,055 | $300,422 |
| Tara N Scott | Vice Pres-Marketing & Communications | 50.0 |
Key Emp
|
$182,649 | $41,451 | $224,100 |
| Andrew Schneider | Associate Vice Pres-Comm Systems | 50.0 |
Highest
|
$166,305 | $27,911 | $194,216 |
| Brandon Baker | Associate Vice Pres - DR & Center Ops | 50.0 |
Highest
|
$147,309 | $22,868 | $170,177 |
| John E Krischel | Director-Service Delivery | 50.0 |
Highest
|
$142,479 | $22,266 | $164,745 |
| Michelle L Stewart | Controller | 50.0 |
Highest
|
$164,841 | $36,198 | $201,039 |
| Randel Petty | Executive Director-Client Relations | 50.0 |
Highest
|
$141,157 | $27,668 | $168,825 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $155,925,006 | $149,733,070 | $119,943,961 | $6,191,936 |
| 2024 | $146,202,331 | $140,507,319 | $115,110,930 | $5,695,012 |
| 2023 | $138,131,932 | $133,319,786 | $107,891,650 | $4,812,146 |
| 2022 | $135,084,699 | $128,376,114 | $100,987,193 | $6,708,585 |
| 2021 | $144,930,726 | $123,847,115 | $95,667,966 | $21,083,611 |
| 2020 | $117,823,998 | $114,320,892 | $76,132,218 | $3,503,106 |
| 2019 | $108,695,066 | $104,973,186 | $70,238,299 | $3,721,880 |
| 2018 | $103,379,574 | $101,608,929 | $66,891,279 | $1,770,645 |
Compare Oklahoma Blood Institute with other nonprofits in Oklahoma and across the country.